Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans

Diabetes

Volumn 42, Issue 7, 1993, Pages 995-1002

  De Feo, Pierpaolo ^a,b   Volpi, Elena ^a   Lucidi, Paola ^a   Cruciani, Guido ^a   Reboldi, Gianpaolo ^a   Siepi, Donatella ^a   Mannarino, Elmo ^a   Santeusanio, Fausto ^a   Brunetti, Paolo ^a   Bolli, Geremia B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Internal Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTITHROMBIN III; APOLIPOPROTEIN B100; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEUCINE; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS;

ADULT; ANALYSIS OF VARIANCE; ANTITHROMBIN III; APOLIPOPROTEINS B; BLOOD GLUCOSE; BLOOD PROTEINS; C-PEPTIDE; CARBON RADIOISOTOPES; FEMALE; FIBRINOGEN; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN; ISOLEUCINE; KETO ACIDS; LEUCINE; LIVER; MALE; RADIOISOTOPE DILUTION TECHNIQUE; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T;

EID: 0027200188     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.42.7.995     Document Type: Article

References (65)

1. Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews DE, Bier DM, Young VR: Insulin-mediated reduction of whole body protein breakdown: dose-response effects on Leu metabolism in postabsorptive men. J Clin Invest 76:2306-11, 1985
2. Tessari P, Trevisan R, Inchiostro S, Biolo G, Nosadini R, De Kreutzenberg SV, Duner E, Tiengo A, Crepaldi G: Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol 251:E334-42, 1986
3. Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S. Duner E, Biolo G, Marescotti C, Tiengo A, Crepaldi G: Defective suppression by insulin of leucine-carbon appearance and oxidation in type I, insulin dependent diabetes mellitus: evidence for insulin resistance involving glucose and amino acid metabolism. J Clin Invest 77:1797-804, 1986
4. Tessari P, Inchiostro S, Biolo G, Trevisan R, Fantin G, Marescotti MC, Iori E, Tiengo A, Crepaldi G: Differential effects of hyperin-sulimemia and hyperaminoacidemia on leucine-carbon metabolism in vivo: evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest 79:1062-69, 1987
5. Castellino P, Luzi L. Simonson DC, Haymond M, DeFronzo RA: Effect ot insulin and plasma amino acid concentrations on leucine meatabolism in man: role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 80:1784-93, 1987
6. Tessari P, Pehling G, Nissen SL, Gerich JE, Service FJ, Rizza, RA, Haymond MW: Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans. Diabetes 37:512-19, 1988
7. Flakoll PJ, Kulaylat M, Frexes-Steed M, Hourani H, Brown LL, Hill JO, Abumrad NN: Amino acids augment insulin's suppression of whole body proteolysis. Am J Physiol 257:E839-47, 1989
8. Lecavalier L, De Feo, P, Haymond MW: Isolated hypoisoleuchinemia impairs whole body but not hepatic protein synthesis in humans. Am J Physiol 261:E578-86, 1991
9. Bennet WM, Connacher AA, Jung RT, Stehle P, Rennie MJ: Effects of insulin and amino acids on leg protein turnover in IDDM patients. Diabetes 40:499-508, 1991
10. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D: Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25:400-03, 1983
11. Robert JJ, Beaufrere B, Koziet J, Desjeux JF, Bier DM, Young VR, Lestradet H: Whole body de novo amino acid synthesis type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine, alanine, and glycine. Diabetes 34:67-73, 1985
12. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sönksen PH: The effect of metabolic control on leucine metabolism in type I (insulin-dependent) diabetic patients. Diabelologia 29:131-41, 1986
13. Nair KS, Ford GC, Halliday D: Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type I diabetic patients. Metabolism 36:491-95, 1987
14. Pacy PJ, Nair Ks, Ford C, Halliday D: Failure of insulin infusion to stimulate fractional muscle protein synthesis in type I diabetic patients. Anabolic effect of insulin and decreased proteolysis. Diabetes 38:618-24, 1989
15. 13C]leucine. Diabetologia 33:43-51, 1990
16. Luzi L, Castellino P, Simonson DC, Petrides AS, DeFronzo RA: Leucine metabolism in IDDM: role of insulin and substrate availability. Diabetes 39:38-48, 1990
17. De Feo P, Gan Gaisano M, Haymond MW: Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833-40, 1991
18. 5]phenylalnine methodologies. Clin Sci 80:345-52, 1991
19. Jefferson LS: Role of insulin in the regulation of protein synthesis. Diabetes 29:487-96, 1980
20. Flaim DE, Copenhaver ME, Jefferson LS: Effects of diabetes on protein synthesis in fast- and slow-twitch rat skeletal muscle. Am J Physiol 239:E88-95, 1980
21. Airhart J, Arnold JA, Stirewalt WS, Low RB: Insulin stimulation of protein synthesis in cultured skeletal and cardiac muscle cells. Am J Physiol 243:C81-86, 1982
22. Pain VM, Albertse EC, Garlick PJ: Protein metabolism in skeletal muscle, diaphragm and heart of diabetic rats. Am J Physiol 245: E604-10, 1983
23. Flaim KE, Hutson SM, Lloyd CE, Taylor JM, Shiman R, Jefferson LS: Direct effect of insulin on albumin gene expression in primary cultures of rat hepatocytes. Am J Physiol 249:E447-53, 1985
24. Granner DK, Andreone T, Sasake K, Beale E: Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature (Lond) 305:549-51, 1983
25. Dillmann WH: Diabetes mellitus-induced changes in the concentration of specific mRNAs and proteins. Diabetes Metab Rev 4:789-97, 1988
26. Schwenk WR, Beaufrere B, Haymond MW: Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol 249:E646-50, 1985
27. McGuire E, Helderman J, Tobin J, Andres R, Berman M: Effects of arterial venous sampling on analysis of glucose kinetics in man. J Appl Physiol 249:565-73, 1976
28. 3 leucine in man. In Proceedings of the 4th International Radiopharmaceutical Dosimetry Symposium. Oakridge, TN, Oakridge Associated Universities, 1986, p. 681-87
29. Herbert V, Lau K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-84, 1965
30. Faber O, Binder C, Markussen J, Heding L, Haithani V, Kuzuya H, Blix P, Horwitz D, Rubenstein A: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-77, 1978
31. Doumas BT, Watson W, Biggs HG: Albumin standards and the measurement of serum albumin with brocresol green. Clin Chim Acta 31:87-96, 1971
32. Jacobsoon K: Studies on determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest 7:14-19, 1955
33. Rautela GS, Liedtke RJ: Automated enzymic measurement of total cholesterol in serum. Clin Chem 24:108-14, 1978
34. Burnstein M, Scholnick HR, Morfin R: Rapid method for isolation of lipoproteins from human serum by precipitation by polyanions. J Lipid Res 11:583-95, 1970
35. Rautela GS, Hall RG Jr, Bekiesz CL, Wermus GR. A kinetic method for the rapid and automatic measurement of triglycerides in biological fluids. Clin Chem 20:847-51, 1974
36. Horber FF, Kahl J, Lecavalier L, Krom B. Haymond MW: Determination of leucine and α-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography. J Chromatogr 495: 81-94, 1989
37. Nissen S, Haymond MW: Changes in leucine kinetics during meal absorption: effect of dietary leucine availability. Am J Physiol 250: E695-701, 1986
38. Cox AM, Turner R, Cooper EH: Separation and characterization of glycoproteins from normal, pregnancy, and acute inflammatory sera. J Chromatogr 397:213-22, 1987
39. Virgolini I, Angelberger P, Lupattelli G, Li S, Pidlich J, Molinari E, Sinzinger H: Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitro. Nucl Med Biol 18:513-17, 1992
40. Egusa G, Brady DW, Grundy SM, Howard BV: Isopropanol precipitation method for the determination of apolioprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 24:1261-67, 1983
41. Allsop JR, Wolfe RR, Burke JF: Tracer priming the bicarbonate pool. J Appl Physiol 45:137-39, 1978
42. Layman DK, Wolfe RR: Sample site selection for tracer studies applying a unidirectional circulatory approach. Am J Physiol 253: E173-78, 1987
43. Horber FF, Horber-Feyder CM, Krayer S, Schwenk WF, Haymond MW: Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am J Physiol 257:E385-99, 1989
44. Venkatesan S, Pacy PJ, Wenham D, Halliday D: Very-low-density lipoprotein-apolipoprotein B turnover studies in normal subjects: a stable isotope study Biochem Soc Trans 18:1192-93, 1990
45. Arends J, Ostlund RE, Bier DM: Measurement of in vivo protein synthesis using stable isotopes: comparison of four different amino acid tracers. In Protein Metabolism in Diabetes Mellitus. Burlington, VT, University of Vermont, 1991, p. 11
46. Glaumann H, Ericsson JLE: Evidence for the participation of the Golgi apparatus in the intravascular transport of nascent albumin in the liver cell. J Cell Biol 47:555-67, 1970
47. Peters TJ, Fleischer B, Fleischer S: The biosynthesis of rat serum albumin. IV Apparent passage of albumin through the Golgi apparatus during secretion. J Biol Chem 246:240-44, 1971
48. 131-labeled human serum albumin: distribution and degradations studies. J Clin Invest 32:746-68, 1953
49. Collen D. Schetz J, De Cock F, Holmer E, Verstraete M: Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest 7:27-35 1977
50. Knot EAR, de Jong E, ten Cate JV, Iburg AHC, Henny CP, Bruin T, Stibbe J: Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model. Blood 67:93-98, 1986
51. Winer BJ: Statistical Principles in Experimental Design. 2nd ed. New York, McGraw-Hill, 1972, p. 261-308
52. Snedecor GW, Cochran WG: Statistical Methods. 7th ed. Ames, Iowa State University Press, 1980
53. Schwenk WF, Rubanyi E, Haymond MW: Effect of a protein synthetic inhibitor on in vivo estimates of protein synthesis in dogs. Am J Physiol 252:E595-98, 1987
54. Nair KS, Halliday D, Griggs RC: Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol 254:E208-13, 1988
55. Peavy DE, Taylor JM, Jefferson LS: Time course of changes in albumin synthesis and mRNA in diabetic and insulin-treated diabetic rats. Am J Physiol 248:E656-63, 1985
56. De Feo P, Perriello G, De Cosmo S, Ventura M, Campbell P, Brunetti P, Gerich J, Bolli G: Comparison of glucose conterregulation during short-term and prolonged hypoglycemia in normal man. Diabetes 35:563-69, 1986
57. De Feo P, Horber FF, Haymond MW: Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans. Am J Physiol 263:E794-99, 1992
58. Yedgar S, Carew TE, Pittman RC, Beltz WF, Steinberg D: Tissue sites of catabolism of albumin in rats. Am J Physiol 244:E101-07, 1983
59. Hilstead J, Christensen NJ: Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 35:99-103, 1992
60. Ernst E: Plasma fibrinogen - an independent cardiovascular risk factor. J Intern Med 227:365-72, 1990
61. Ceriello D, Quatraro A, Marchi E, Barbanti M, Dell Russo P, Lefèbvre P, Giugliano D: The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabetic Med 7:343-48, 1990
62. Marongiu F, Conti M, Mameli G, Sorano GG, Cossu E, Cirillo R, Balestrieri A. Is the imbalance between thrombin and plasmir activity in diabetes related to the behaviour of antiplasmin activity? Thromb Res 58:91-99, 1990
63. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefèbvre P: Evidence for a hyperglycaemia-dependent decrease of an tithrombin III-thrombin complex formation in humans. Diabetolgia 33:163-67, 1990
64. Patsch W, Franz S, Schonfeld G: Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 71:1161-74, 1983
65. Jackson TK, Salhanick AI, Elovson J, Deichman ML, Amatruda JM: Insulin regulates apolipoprotein B turnover an phosporylation in rat hepatocytes. J Clin Invest 86:1746-51, 1990